CN101948518A - 用蜂王浆制备功能蛋白RJCPs的方法与应用 - Google Patents
用蜂王浆制备功能蛋白RJCPs的方法与应用 Download PDFInfo
- Publication number
- CN101948518A CN101948518A CN 201010256161 CN201010256161A CN101948518A CN 101948518 A CN101948518 A CN 101948518A CN 201010256161 CN201010256161 CN 201010256161 CN 201010256161 A CN201010256161 A CN 201010256161A CN 101948518 A CN101948518 A CN 101948518A
- Authority
- CN
- China
- Prior art keywords
- royal jelly
- rjcps
- cell
- functional protein
- serum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940109850 royal jelly Drugs 0.000 title claims abstract description 82
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 64
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 63
- 238000000034 method Methods 0.000 title claims abstract description 22
- 241000238631 Hexapoda Species 0.000 claims abstract description 18
- 230000010261 cell growth Effects 0.000 claims abstract description 12
- 238000000502 dialysis Methods 0.000 claims abstract description 11
- 238000004108 freeze drying Methods 0.000 claims abstract description 7
- 239000003102 growth factor Substances 0.000 claims abstract description 7
- 241001465754 Metazoa Species 0.000 claims abstract description 5
- 238000010612 desalination reaction Methods 0.000 claims abstract description 4
- 239000008176 lyophilized powder Substances 0.000 claims description 11
- 241000282414 Homo sapiens Species 0.000 claims description 10
- 101001116000 Apis mellifera Major royal jelly protein 1 Proteins 0.000 claims description 7
- 238000001262 western blot Methods 0.000 claims description 6
- 238000001962 electrophoresis Methods 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 3
- 238000013016 damping Methods 0.000 claims description 3
- 230000028993 immune response Effects 0.000 claims description 3
- 239000012888 bovine serum Substances 0.000 abstract description 11
- 230000004083 survival effect Effects 0.000 abstract description 7
- 230000012010 growth Effects 0.000 abstract description 6
- 239000000843 powder Substances 0.000 abstract description 5
- 239000007853 buffer solution Substances 0.000 abstract 1
- 210000005260 human cell Anatomy 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 104
- 210000002966 serum Anatomy 0.000 description 56
- 244000309466 calf Species 0.000 description 50
- 239000000243 solution Substances 0.000 description 31
- 241000256844 Apis mellifera Species 0.000 description 26
- 239000000047 product Substances 0.000 description 17
- 230000001413 cellular effect Effects 0.000 description 15
- 239000012679 serum free medium Substances 0.000 description 15
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 14
- 235000015097 nutrients Nutrition 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 238000012258 culturing Methods 0.000 description 11
- 239000001963 growth medium Substances 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 10
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 8
- 230000001464 adherent effect Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 230000001954 sterilising effect Effects 0.000 description 8
- 238000004659 sterilization and disinfection Methods 0.000 description 8
- 238000004113 cell culture Methods 0.000 description 7
- 206010009944 Colon cancer Diseases 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 238000004321 preservation Methods 0.000 description 6
- 229930182555 Penicillin Natural products 0.000 description 5
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 5
- 229940049954 penicillin Drugs 0.000 description 5
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 210000002919 epithelial cell Anatomy 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 206010003694 Atrophy Diseases 0.000 description 3
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 239000012980 RPMI-1640 medium Substances 0.000 description 3
- 102000013275 Somatomedins Human genes 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 210000004102 animal cell Anatomy 0.000 description 3
- 230000037444 atrophy Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 208000029742 colonic neoplasm Diseases 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 235000020776 essential amino acid Nutrition 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000007667 floating Methods 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 210000004907 gland Anatomy 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000029052 metamorphosis Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000009010 Bradford assay Methods 0.000 description 2
- 102000008192 Lactoglobulins Human genes 0.000 description 2
- 108010060630 Lactoglobulins Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010033128 Ovarian cancer Diseases 0.000 description 2
- 206010061535 Ovarian neoplasm Diseases 0.000 description 2
- 241000594182 Sarcophaga sigma Species 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000009341 apiculture Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000003119 immunoblot Methods 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000005374 membrane filtration Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- -1 salt ion Chemical class 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 210000001082 somatic cell Anatomy 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 108091093088 Amplicon Proteins 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000256836 Apis Species 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000710780 Bovine viral diarrhea virus 1 Species 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000003951 Erythropoietin Human genes 0.000 description 1
- 108090000394 Erythropoietin Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 102000013566 Plasminogen Human genes 0.000 description 1
- 108010051456 Plasminogen Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- PPBOKXIGFIBOGK-BDTUAEFFSA-N bvdv Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C1=CN=CN1 PPBOKXIGFIBOGK-BDTUAEFFSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000009402 cross-breeding Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000012407 engineering method Methods 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000006481 glucose medium Substances 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 231100000652 hormesis Toxicity 0.000 description 1
- 230000002895 hyperchromatic effect Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 210000001465 kenyon cell Anatomy 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000012151 protein quantification reagent Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 229960004854 viral vaccine Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Images
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010256161 CN101948518B (zh) | 2010-08-17 | 2010-08-17 | 用蜂王浆制备功能蛋白RJCPs的方法与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010256161 CN101948518B (zh) | 2010-08-17 | 2010-08-17 | 用蜂王浆制备功能蛋白RJCPs的方法与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101948518A true CN101948518A (zh) | 2011-01-19 |
CN101948518B CN101948518B (zh) | 2013-02-27 |
Family
ID=43452159
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201010256161 Active CN101948518B (zh) | 2010-08-17 | 2010-08-17 | 用蜂王浆制备功能蛋白RJCPs的方法与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101948518B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103772497A (zh) * | 2014-01-10 | 2014-05-07 | 浙江大学 | 蜂王浆中得到王浆主蛋白和活性滤后液的超滤膜分离方法 |
CN109608516A (zh) * | 2019-01-23 | 2019-04-12 | 中国农业科学院蜜蜂研究所 | 蜂王浆主蛋白1、2、3的快速纯化方法 |
CN118146339A (zh) * | 2024-05-13 | 2024-06-07 | 中国农业科学院蜜蜂研究所 | 意蜂mrjp1突变体及其作为内标蛋白在蜂产品分析中的应用 |
-
2010
- 2010-08-17 CN CN 201010256161 patent/CN101948518B/zh active Active
Non-Patent Citations (3)
Title |
---|
《AGRICULTURAL and FOOD CHEMISTRY》 20071231 LI JIANKE等 Proteomic Analysis of Royal Jelly from Three Strains of Western Honeybees (Apis mellifera) 第8411-8422页 1-4 第55卷, 第21期 * |
《Bioscience,Biotechnology,and Biochenistry》 20011231 Kamakura等 Storage-dependent degradation of 57-kDa protein in Royal Jelly:a possible Marker for Freshness 第277-284页 1-4 第65卷, 第2期 * |
《昆虫知识》 20080229 陶挺等 蜂王浆蛋白生物学功能的研究 第33-37页 1-4 第45卷, 第1期 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103772497A (zh) * | 2014-01-10 | 2014-05-07 | 浙江大学 | 蜂王浆中得到王浆主蛋白和活性滤后液的超滤膜分离方法 |
CN109608516A (zh) * | 2019-01-23 | 2019-04-12 | 中国农业科学院蜜蜂研究所 | 蜂王浆主蛋白1、2、3的快速纯化方法 |
CN109608516B (zh) * | 2019-01-23 | 2020-11-27 | 中国农业科学院蜜蜂研究所 | 蜂王浆主蛋白1、2、3的快速纯化方法 |
CN118146339A (zh) * | 2024-05-13 | 2024-06-07 | 中国农业科学院蜜蜂研究所 | 意蜂mrjp1突变体及其作为内标蛋白在蜂产品分析中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN101948518B (zh) | 2013-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10412941B2 (en) | Artificial feeding method at low altitude for host insect ghost moth of ophiocordyceps sinensis | |
CN101491228B (zh) | 一种培育海水无核珍珠的方法 | |
CN103667176A (zh) | 鲤疱疹病毒ⅱ型敏感的异育银鲫脑组织细胞系及其建立方法和应用 | |
CN108220227A (zh) | 一种通过全悬浮传代细胞系悬浮培养新城疫病毒的方法 | |
CN109069546A (zh) | 可食用燕窝提取物和提取方法 | |
CN102559739B (zh) | 重组人源lect2蛋白在毕赤酵母中的表达及纯化方法 | |
CN108300704A (zh) | 一种用传代细胞系悬浮培养传染性支气管炎病毒的方法 | |
CN106397629A (zh) | 从鲟鱼鱼骨中提取硫酸软骨素的方法、由该方法提取的硫酸软骨素及应用 | |
CN104974977B (zh) | 一种鞍带石斑鱼肾组织细胞系及其构建方法 | |
CN101948518B (zh) | 用蜂王浆制备功能蛋白RJCPs的方法与应用 | |
CN102268402A (zh) | 无血清培养基及cho细胞中高效表达促红素的培养方法 | |
CN104152403B (zh) | 一种建立鹅胚上皮细胞系的方法及建立的鹅胚上皮细胞系 | |
CN107629996A (zh) | 一株草鱼胸鳍细胞系的构建方法 | |
CN105154389A (zh) | 一种适于pk-15细胞生长的低血清无蛋白培养基及其制备方法 | |
CN103386127B (zh) | 用鸡胚传代细胞系和生物反应器培养新城疫病毒制备疫苗的方法 | |
CN102886043B (zh) | 猪乙型脑炎病毒与猪细小病毒二联灭活疫苗及其制备方法 | |
CN105176915A (zh) | 一种适于Marc-145细胞生长的低血清无蛋白培养基及其制备方法 | |
CN106867916A (zh) | 冬虫夏草菌丝体培养方法 | |
CN101451121B (zh) | 褐点石斑鱼心脏细胞系的构建方法 | |
CN105861416A (zh) | 一种用于全悬浮培养昆虫细胞的无血清培养基及其制备方法和应用 | |
CN110331098A (zh) | 一种促进蔓枯病病原菌产孢子的方法 | |
CN104726400A (zh) | 人多能干细胞向生殖细胞分化的无动物源组分培养方法 | |
CN105087489A (zh) | 一种dc细胞培养试剂及其培养方法 | |
CN106967651A (zh) | 一种鸡毒支原体培养基及其制备方法 | |
CN108342429A (zh) | 一种银耳孢子发酵高产银耳多糖的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: HANGZHOU BIYUTIAN HEALTH PRODUCTS CO., LTD. Free format text: FORMER OWNER: ZHEJIANG UNIVERSITY Effective date: 20121226 Owner name: ZHEJIANG UNIVERSITY Effective date: 20121226 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Shen Lirong Inventor after: Mo Yinyuan Inventor after: Zhang Weiguang Inventor after: Chen Yi Inventor after: Lai Chaoqiang Inventor after: Yuan Peng Inventor after: Zhang Liwen Inventor after: Yin Zhihong Inventor after: Qiu Wei Inventor before: Shen Lirong Inventor before: Mo Yinyuan Inventor before: Zhang Weiguang Inventor before: Chen Yi Inventor before: Lai Chaoqiang Inventor before: Yuan Peng Inventor before: Zhang Liwen |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: SHEN LIRONG MO YINYUAN ZHANG WEIGUANG CHEN YI LAI CHAOQIANG YUAN PENG ZHANG LIWEN TO: SHEN LIRONG MO YINYUAN ZHANG WEIGUANG CHEN YI LAI CHAOQIANG YUAN PENG ZHANG LIWEN YIN ZHIHONG QI WEI Free format text: CORRECT: ADDRESS; FROM: 310027 HANGZHOU, ZHEJIANG PROVINCE TO: 311501 HANGZHOU, ZHEJIANG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20121226 Address after: 311501 Zhejiang province Tonglu Tongjun Street mulberry Road No. 18 Applicant after: Hangzhou Biyutian Health Products Co.,Ltd. Applicant after: Zhejiang University Address before: 310027 Hangzhou, Zhejiang Province, Xihu District, Zhejiang Road, No. 38, No. Applicant before: Zhejiang University |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |